SI1162993T1 - Use of casb616 polypeptides and polynucleotides for cancer treatment - Google Patents

Use of casb616 polypeptides and polynucleotides for cancer treatment

Info

Publication number
SI1162993T1
SI1162993T1 SI200030661T SI200030661T SI1162993T1 SI 1162993 T1 SI1162993 T1 SI 1162993T1 SI 200030661 T SI200030661 T SI 200030661T SI 200030661 T SI200030661 T SI 200030661T SI 1162993 T1 SI1162993 T1 SI 1162993T1
Authority
SI
Slovenia
Prior art keywords
polynucleotides
cancer treatment
casb616
polypeptides
casb616 polypeptides
Prior art date
Application number
SI200030661T
Other languages
Slovenian (sl)
Inventor
Y De Bassols Carlota Vinals
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9905124.5A external-priority patent/GB9905124D0/en
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of SI1162993T1 publication Critical patent/SI1162993T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
SI200030661T 1999-03-05 2000-02-28 Use of casb616 polypeptides and polynucleotides for cancer treatment SI1162993T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9905124.5A GB9905124D0 (en) 1999-03-05 1999-03-05 Novel compounds
PCT/EP2000/001587 WO2000053216A2 (en) 1999-03-05 2000-02-28 Use of casb616 polypeptides and polynucleotides for cancer treatment
EP00907633A EP1162993B1 (en) 1999-03-05 2000-02-28 Use of casb616 polypeptides and polynucleotides for cancer treatment

Publications (1)

Publication Number Publication Date
SI1162993T1 true SI1162993T1 (en) 2005-10-31

Family

ID=32870683

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030661T SI1162993T1 (en) 1999-03-05 2000-02-28 Use of casb616 polypeptides and polynucleotides for cancer treatment

Country Status (2)

Country Link
DK (1) DK1162993T3 (en)
SI (1) SI1162993T1 (en)

Also Published As

Publication number Publication date
DK1162993T3 (en) 2005-06-20

Similar Documents

Publication Publication Date Title
GB9903841D0 (en) Diagnosis and treatment of cancer
EP1070080A4 (en) HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE
ZA979096B (en) Viral and cancer treatment
SI1716853T1 (en) Treatment of cancers of the human body using ET743
GB9811598D0 (en) Diagnosis and treatment of cancer
IL124650A0 (en) Methods and therapeutic compositions for treating cancer
EP1176940A4 (en) Fingernail hardening treatment
IL149281A0 (en) Treatment of cancer
SI1162993T1 (en) Use of casb616 polypeptides and polynucleotides for cancer treatment
GB9819999D0 (en) Treatment of cancer
ZA200107282B (en) Use of CASB616 polypeptides and polynucleotides for cancer treatment.
PL352681A1 (en) Preventive and therapeutic agents for cancer
AU1439401A (en) Diagnosis and treatment of cancer using star polypeptides and polynucleotides
IL132531A0 (en) Detection and therapy of tumors
GB2343629B (en) Treatment of cellulite
GB9804361D0 (en) Cancer treatment
GB0020261D0 (en) Therapeutic treatment
GB9828564D0 (en) Materials and methods for the treatment and diagnosis of cancer
GB9911183D0 (en) Treatment of cancers
SI1165778T1 (en) Uses of casb618 polynucleotides and polypeptides
GB9927005D0 (en) Treatment of cancers
GB9918534D0 (en) Treatment of cancers
GB9911346D0 (en) Treatment of cancers
GB9927106D0 (en) Cancer treatment
GB9908176D0 (en) Cancer treatment